You are here

World Structural Heart Devices Industry Analysis, 2019 - Leading Players are Abbott Laboratories, Edwards Lifesciences, Medtronic, and Boston Scientific

DUBLIN, March 29, 2019 /PRNewswire/ -- The "Global Structural Heart Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to's offering.

The global structural heart devices market was valued at US$ 7.5 Bn in 2017 and expected to reach US$ 18.9 Bn by 2026, expanding at a CAGR of 10.7% from 2018 to 2026.

Significantly large prevalence of cardiovascular abnormalities. In the U.S. alone approximately 60 million individuals presenting 20% of the total population suffers from structural heart defects. This represents a significant opportunity for the use of structural heart devices. These conditions present a wide category of treatment including both repair and replacement procedures, for both acquired and congenital diseases.

Favorable reimbursements for the novel minimally invasive procedures have made procedures such as TAVR highly popular and affordable to the patients. As the global population is aging, the medical expenditure in several countries is being covered by the government and private insurers. This eases the per capita healthcare burden, therefore urging more and more patients to opt for such treatments. Furthermore, increasing awareness about the novel procedures and increasing availability of long-lasting implants drive the global market growth.

The major market players are also increasing their investments in research and development activities to enhance the effectiveness of these devices. It is expected that by 2020 some prominent and advanced pipeline products shall be commercialized. Boston Scientific Corporation, Abbott Laboratories, Medtronic, Edwards Lifesciences Corporation are some of the leading companies in this space.

Based on the type of devices, the global structural heart devices market is segmented into heart valve devices, repair devices, and accessories. Among these, the demand for heart valve devices is set to be the highest during the forecast period. Similarly, the replacement procedures segment in terms of procedure types is estimated to undergo the fastest market growth. Consistent growth in the geriatric population, rapid adoption of transcatheter aortic valve replacement therapies, and an affordable process of replacement procedures contribute to the rapid growth of this segment.

Additionally, North America and Asia Pacific markets are the most prominent regions to watch during the forecast period in terms of revenue and market growth respectively. Asia Pacific region will progress at the fastest CAGR during the forecast period.

Considering the competitive landscape, the global structural heart valve devices have rapidly changing dynamics. The new market entrants with promising pipeline devices are often being acquired by incumbent players with rich financial pool. The existing players are also strengthening their geographical foothold through mergers, distribution agreements, and other growth strategies.

The major players operating in this market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation and others.

Key Market Movements

  • The growing incidence of congenital heart defects, and high prevalence of age-related structural conditions
  • Growing awareness and reducing procedure costs in the Asia Pacific
  • Intensifying market entry of major market players from developed countries to emerging Asia Pacific region
  • Growing demand for minimally invasive procedures, therefore, paving way for transcatheter procedures

Topics Covered

Chapter 1. Preface
1.1. Report Description
1.2. Research Scope
1.3. Research Methodology
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Structural Heart Devices Market Portraiture
2.2. Global Structural Heart Devices Market, by Type, 2017 (US$ Mn)
2.3. Global Structural Heart Devices Market, by Procedure, 2017 (US$ Mn)
2.4. Global Structural Heart Devices Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Structural Heart Devices Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Structural Heart Devices Market, by Key Players, 2017

Chapter 4. Global Structural Heart Devices Market, by Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Heart Valve Devices
4.2.1. Surgical Heart Valves
4.2.2. Transcatheter Heart Valves
4.3. Repair Devices
4.3.1. Occluders and Delivery Systems
4.3.2. Annuloplasty Rings
4.3.3. Others
4.4. Accessories

Chapter 5. Global Structural Heart Devices Market, by Procedure, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Repair Procedures
5.2.1. Valvuloplasty
5.2.2. Transcatheter Mitral Valve Repair (TMVR)
5.2.3. Annuloplasty
5.2.4. Others
5.3. Replacement Procedures
5.3.1. Tissue Heart Valves
5.3.2. Mechanical Heart Valves
5.3.3. Transcatheter Aortic Valve Replacement (TAVR)

Chapter 6. Global Structural Heart Devices Market, by Geography, 2016-2026 (US$ Mn)
6.1. Overview
6.2. North America Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
6.3. Europe Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
6.4. Asia Pacific Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
6.5. Latin America Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
6.6. Middle East & Africa Structural Heart Devices Market, 2016 - 2026 (US$ Mn)

Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Boston Scientific Corporation
7.3. Edwards Lifesciences Corporation
7.4. Medtronic PLC
7.5. LivaNova PLC
7.6. C. R. Bard Inc.
7.7. CryoLife Inc.
7.8. Integer Holdings Corporation
7.9. Comed B.V.
7.10. JenaValve Technology Inc.

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets